chr8-143567361-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001100878.2(MROH6):​c.2038G>A​(p.Gly680Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000327 in 1,222,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000019 ( 0 hom. )

Consequence

MROH6
NM_001100878.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -7.64

Publications

0 publications found
Variant links:
Genes affected
MROH6 (HGNC:27814): (maestro heat like repeat family member 6)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06168455).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MROH6NM_001100878.2 linkc.2038G>A p.Gly680Arg missense_variant Exon 14 of 14 ENST00000398882.8 NP_001094348.1 A6NGR9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MROH6ENST00000398882.8 linkc.2038G>A p.Gly680Arg missense_variant Exon 14 of 14 5 NM_001100878.2 ENSP00000381857.3 A6NGR9

Frequencies

GnomAD3 genomes
AF:
0.0000135
AC:
2
AN:
147634
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000307
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000186
AC:
2
AN:
1075174
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
508328
show subpopulations
African (AFR)
AF:
0.0000444
AC:
1
AN:
22536
American (AMR)
AF:
0.00
AC:
0
AN:
8124
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13946
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25828
South Asian (SAS)
AF:
0.00
AC:
0
AN:
21122
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2872
European-Non Finnish (NFE)
AF:
0.00000109
AC:
1
AN:
916214
Other (OTH)
AF:
0.00
AC:
0
AN:
43168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000135
AC:
2
AN:
147634
Hom.:
0
Cov.:
33
AF XY:
0.0000138
AC XY:
1
AN XY:
72282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40950
American (AMR)
AF:
0.00
AC:
0
AN:
14860
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10226
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
304
European-Non Finnish (NFE)
AF:
0.0000307
AC:
2
AN:
65178
Other (OTH)
AF:
0.00
AC:
0
AN:
2018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 15, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2038G>A (p.G680R) alteration is located in exon 14 (coding exon 14) of the MROH6 gene. This alteration results from a G to A substitution at nucleotide position 2038, causing the glycine (G) at amino acid position 680 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.019
DANN
Benign
0.91
DEOGEN2
Benign
0.00085
T;.;.;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.35
.;.;.;T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.062
T;T;T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.090
N;.;.;.
PhyloP100
-7.6
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.34
N;N;N;N
REVEL
Benign
0.038
Sift
Benign
0.56
T;T;T;T
Sift4G
Uncertain
0.018
D;T;T;T
Polyphen
0.012
B;.;.;.
Vest4
0.089
MutPred
0.17
Gain of methylation at G680 (P = 0.0274);.;.;.;
MVP
0.014
MPC
0.018
ClinPred
0.051
T
GERP RS
-7.3
Varity_R
0.038
gMVP
0.16
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1367025540; hg19: chr8-144649531; API